For: | Okamoto K, Maeda H, Shiga T, Shiga M, Dabanaka K, Hanazaki K, Kobayashi M. Cetuximab and panitumumab in a patient with colon cancer and concomitant chronic skin disease: A potential beneficial effect on psoriasis vulgaris. World J Gastroenterol 2015; 21(12): 3746-3749 [PMID: 25834345 DOI: 10.3748/wjg.v21.i12.3746] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i12/3746.htm |
Number | Citing Articles |
1 |
Aurore Le, Abdulkader Azouz, Séverine Thomas, Nicolas Istaces, Muriel Nguyen, Stanislas Goriely. JNK1 Signaling Downstream of the EGFR Pathway Contributes to Aldara®-Induced Skin Inflammation. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.604785
|
2 |
|
3 |
Xuan Xu, Hong-Yu Zhang. The Immunogenetics of Psoriasis and Implications for Drug Repositioning. International Journal of Molecular Sciences 2017; 18(12): 2650 doi: 10.3390/ijms18122650
|
4 |
Fenlai Tan, Guiqun Yang, Yanping Wang, Haibo Chen, Bo Yu, He Li, Jing Guo, Xiaoling Huang, Yifang Deng, Pengxia Yu, Lieming Ding. Icotinib inhibits EGFR signaling and alleviates psoriasis-like symptoms in animal models. Biomedicine & Pharmacotherapy 2018; 98: 399 doi: 10.1016/j.biopha.2017.12.073
|
5 |
Zhaoxia Chen, Dongmei Zhou, Yan Wang, Haibing Lan, Xingwu Duan, Bohua Li, Jingxia Zhao, Wei Li, Zhengrong Liu, Tingting Di, Xinwei Guo, Jinchao Zhang, Bo Li, Shuo Feng, Ping Li. Fire needle acupuncture or moxibustion for chronic plaque psoriasis: study protocol for a randomized controlled trial. Trials 2019; 20(1) doi: 10.1186/s13063-019-3736-2
|
6 |
Maria Lapteva, Marwa A. Sallam, Alexandre Goyon, Davy Guillarme, Jean-Luc Veuthey, Yogeshvar N. Kalia. Non-invasive targeted iontophoretic delivery of cetuximab to skin. Expert Opinion on Drug Delivery 2020; 17(4): 589 doi: 10.1080/17425247.2020.1731470
|
7 |
Vrinda Madan, Laura I. Ortiz-López, Goranit Sakunchotpanit, Ryan Chen, Krithika Nayudu, Vinod E. Nambudiri. Psoriasis in the Era of Targeted Cancer Therapeutics: A Systematic Review on De Novo and Pre-existing Psoriasis in Oncologic Patients Treated with Emerging Anti-neoplastic Agents. Dermatology and Therapy 2024; 14(7): 1755 doi: 10.1007/s13555-024-01198-w
|
8 |
Elena Marinello, Davide Pastorelli, Mauro Alaibac. A case of psoriasis pustolosa palmaris induced by cetuximab. BMJ Case Reports 2016; : bcr2016214582 doi: 10.1136/bcr-2016-214582
|
9 |
Xiuju Dai, Masamoto Murakami, Ken Shiraishi, Jun Muto, Mikiko Tohyama, Hideki Mori, Ryo Utsunomiya, Koji Sayama. EGFR ligands synergistically increase IL‐17A‐induced expression of psoriasis signature genes in human keratinocytes via IκBζ and Bcl3. European Journal of Immunology 2022; 52(6): 994 doi: 10.1002/eji.202149706
|
10 |
Sandra Rayego-Mateos, Raul Rodrigues-Diez, Jose Luis Morgado-Pascual, Floris Valentijn, Jose M. Valdivielso, Roel Goldschmeding, Marta Ruiz-Ortega. Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage. Mediators of Inflammation 2018; 2018: 1 doi: 10.1155/2018/8739473
|
11 |
Yingjian Huang, Yuqian Wang, Yunyue Zhen, Wancheng Liu, Yan Wang, Ruijie Wang, Ning Wang, Shan Huang, Jianjun Yan, Qing Sun. LPCAT1 Facilitates Keratinocyte Hyperproliferation and Skin Inflammation in Psoriasis by Regulating GLUT3. Journal of Investigative Dermatology 2024; 144(7): 1479 doi: 10.1016/j.jid.2024.01.004
|
12 |
Aki Natsumi, Koji Sugawara, Makiko Yasumizu, Yukari Mizukami, Shigetoshi Sano, Akimichi Morita, Ralf Paus, Daisuke Tsuruta. Re-investigating the Basement Membrane Zone of Psoriatic Epidermal Lesions: Is Laminin-511 a New Player in Psoriasis Pathogenesis?. Journal of Histochemistry & Cytochemistry 2018; 66(12): 847 doi: 10.1369/0022155418782693
|
13 |
L. Peng, Q. Li, H. Wang, J. Wu, C. Li, Y. Liu, J. Liu, L. Xia, Y. Xia. Fn14 deficiency ameliorates psoriasis-like skin disease in a murine model. Cell Death & Disease 2018; 9(8) doi: 10.1038/s41419-018-0820-6
|